CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-03). The draft was written by AI, the existence of all 2 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 2068 · Search date 2026-08-03 · Methodology v0.6

Black pepper plus turmeric,
does it really help with Greater chronic-pain reduction than turmeric alone?

30-Second Summary
D
Evidence Grade D · 32 · Safety caution
Black pepper did not add pain relief to culinary-dose turmeric
One participant withdrew because of gastrointestinal symptoms. Piperine can alter drug exposure, so people taking medicines such as anticoagulants should seek professional advice before high-dose combinations.
What the
research shows
The grade is D with 32 points. A prospectively registered crossover trial randomized 30 adults with moderate chronic pain and analyzed 29. Adding pepper did not improve the registered primary 0-to-10 pain outcome, P=0.157, and there was no interaction with turmeric dose, P=0.338.
What the
ads claim
Pepper 0.3 g is about 0.13 teaspoon, 0.043 tablespoon, or one pinch; turmeric doses are about 0.1, 0.33, and 1 teaspoon. These are culinary amounts, but capsules were used, and increased absorption cannot be translated into reduced pain.
*

Useful facts when choosing a product

  • Piperine content varies across Korean retail peppers, and this pain trial did not assay its actual 0.3 g pepper dose.
  • Purified piperine 20 mg increased pharmacokinetic exposure to 2 g curcumin in a different formulation and dose setting.
  • Verdict 064 is C with 48 points for standardized curcumin and verdict 1306 is C with 48 points for muscle soreness; this verdict tests the incremental pain effect of culinary turmeric plus pepper.
Gap Measurement · Verdict 2068 · D 32
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Durham 2026 randomized 30 adults aged at least 40 with chronic pain to the sequence of turmeric alone and turmeric plus pepper in a double-masked crossover trial. One withdrew for gastrointestinal symptoms and 29 were analyzed. Each condition and washout lasted one week. Capsules delivered 0.3, 1, or 3 g turmeric and 0.3 g pepper. NCT05206266 was submitted on 2021-12-13 and posted on 2022-01-25 before the 2022-02-13 start, and specified pain as primary. McCormick Science Institute and NIH supported the study; author James O. Hill disclosed receiving an honorarium as a McCormick Science Institute advisory-board member.

02

Why this is classified as D (32)

The prospectively registered patient-centered primary outcome was null, but one imprecise 29-person, one-week, no-placebo trial leaves room for worthwhile benefit, giving D with 32 points.

Counterpoint. This verdict does not deny purified piperine pharmacokinetics; it asks whether that fact translated into less pain with this culinary combination.

Rejudgment record. Cross-check applied — The null prospectively registered primary pain comparison was weighed with the uncertainty from a small, short, active-control crossover design

Scoring profile behind this grade
EndpointPPatient-reported treatment goal - the symptom is the goal
ReplicationR1Single confirmatory trial
IndependenceI1Mixed funding sources
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Incremental pain reduction from added pepperDThe registered primary outcome was null at P=0.157.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Prospectively registered randomized double-masked crossover trial29Support from McCormick Science Institute and NIHSeven-day mean 0-to-10 numeric pain ratingPepper addition P=0.157 and pepper-by-turmeric-dose P=0.338; no between-condition 95% CI reported.Direct null registered primary outcome
§

Receipt — 2 References

All 2 cited sources were verified for existence at the original page (as of 2026-08-03).

Durham L, Oster RA, Hill JO, et al. Bioenhancer Assessment of Black Pepper with Turmeric on Self-Reported Pain Ratings in Adults: A Randomized, Cross-Over, Clinical Trial. Nutrients. 2026;18(2):223. DOI: 10.3390/nu18020223.
checked
Shoba G, Joy D, Joseph T, et al. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64(4):353-356. PMID: 9619120. DOI: 10.1055/s-2006-957450.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-03 · Corrections: none

Cite this verdict

Black pepper plus turmeric x chronic pain Evidence Grade D card
[Chamgap] Black pepper plus turmeric x chronic pain — Evidence Grade D·32. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/general/black-pepper-added-to-turmeric-chronic-pain/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.